Compare ESNT & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESNT | NOVT |
|---|---|---|
| Founded | 2008 | 1968 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.4B |
| IPO Year | 2013 | 1999 |
| Metric | ESNT | NOVT |
|---|---|---|
| Price | $60.77 | $126.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $67.29 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 525.9K | 299.5K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | ★ 0.73 | N/A |
| EPS | ★ 6.90 | 1.47 |
| Revenue | ★ $1,260,935,000.00 | $521,290,000.00 |
| Revenue This Year | N/A | $8.71 |
| Revenue Next Year | $3.18 | $6.47 |
| P/E Ratio | ★ $8.82 | $87.80 |
| Revenue Growth | 1.45 | ★ 35.49 |
| 52 Week Low | $53.31 | $98.27 |
| 52 Week High | $67.09 | $149.95 |
| Indicator | ESNT | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 56.08 |
| Support Level | $60.72 | $111.73 |
| Resistance Level | $61.99 | $128.71 |
| Average True Range (ATR) | 0.97 | 4.21 |
| MACD | 0.36 | 1.98 |
| Stochastic Oscillator | 73.43 | 84.67 |
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.